Thiabendazole adverse reactions: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) (Created page with "__NOTOC__ {{Thiabendazole}} {{CMG}} <ref>{{Cite web | last = | first = | title = http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/16096slr033,16097slr026_mintez...") |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Adverse Reactions== | |||
* '''Gastrointestinal''': [[anorexia]], [[nausea]], [[vomiting]], [[diarrhea]], epigastric distress, [[abdominal pain]], [[jaundice]], [[cholestasis]], parenchymal liver damage and [[hepatic failure]]. (See WARNINGS.) | |||
* '''Central Nervous System''': [[dizziness]], weariness, [[drowsiness]], giddiness, [[headache]], [[numbness]], hyperirritability, [[convulsion]]s, collapse, [[confusion]], [[depression]], floating sensation, [[weakness‘‘ and lack of coordination. | |||
<ref>{{Cite web | last = | first = | title = http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/16096slr033,16097slr026_mintezol_lbl.pdf | url =http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/16096slr033,16097slr026_mintezol_lbl.pdf | publisher = | date = | accessdate = }}</ref> | * '''Special Senses'': [[tinnitus]], abnormal sensation in eyes, xanthopsia, blurred vision, reduced vision, drying of mucous membranes (mouth, eyes, etc.), Sicca syndrome. (See WARNINGS.) | ||
* '''Cardiovascular''': [[hypotension]]. | |||
* '''Metabolic''': [[hyperglycemia]]. | |||
* '''Hematologic''': transient [[leukopenia]]. | |||
* '''Genitourinary''': [[hematuria]], [[enuresis]], malodor of the urine, [[crystalluria]]. | |||
* '''Hypersensitivity''': [[pruritus]], [[fever]], facial flush, [[chills]], conjunctival injection, [[angioedema]], [[anaphylaxis]], skin [[rash]]es (including perianal), [[erythema multiforme]] (including [[Stevens-Johnson syndrome]]), and [[lymphadenopathy]]. | |||
* '''Miscellaneous''': appearance of live Ascaris in the mouth and nose.<ref>{{Cite web | last = | first = | title = http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/16096slr033,16097slr026_mintezol_lbl.pdf | url =http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/16096slr033,16097slr026_mintezol_lbl.pdf | publisher = | date = | accessdate = }}</ref> | |||
==References== | ==References== | ||
Revision as of 23:05, 6 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Adverse Reactions
- Gastrointestinal: anorexia, nausea, vomiting, diarrhea, epigastric distress, abdominal pain, jaundice, cholestasis, parenchymal liver damage and hepatic failure. (See WARNINGS.)
- Central Nervous System: dizziness, weariness, drowsiness, giddiness, headache, numbness, hyperirritability, convulsions, collapse, confusion, depression, floating sensation, [[weakness‘‘ and lack of coordination.
- 'Special Senses: tinnitus, abnormal sensation in eyes, xanthopsia, blurred vision, reduced vision, drying of mucous membranes (mouth, eyes, etc.), Sicca syndrome. (See WARNINGS.)
- Cardiovascular: hypotension.
- Metabolic: hyperglycemia.
- Hematologic: transient leukopenia.
- Genitourinary: hematuria, enuresis, malodor of the urine, crystalluria.
- Hypersensitivity: pruritus, fever, facial flush, chills, conjunctival injection, angioedema, anaphylaxis, skin rashes (including perianal), erythema multiforme (including Stevens-Johnson syndrome), and lymphadenopathy.
- Miscellaneous: appearance of live Ascaris in the mouth and nose.[1]
References
- ↑ "http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/16096slr033,16097slr026_mintezol_lbl.pdf" (PDF). External link in
|title=(help)
Adapted from the FDA Package Insert.